Swiftarc Venture Labs Announces Inaugural Portfolio Investment in R-Zero Through Its Seed and $15 Million Series A Financing Rounds SAN FRANCISCO, November 13, 2020-- Swiftarc Ventures, LLC an early and growth stage Venture Capital Firm focused on the next generation of Consumer and Consumer Health disruptors, has made its first portfolio investment in biosafety startup R-Zero, which reduces the spread of infectious diseases through their initial product, "Arc", a hospital-grade UV-C disinfecting device designed for commercial use including restaurants, hotels, offices, and schools.